Five of the most recent microscopy developments
Drug Target Review highlights five of the latest imaging advancements in the field of microscopy.
List view / Grid view
Drug Target Review highlights five of the latest imaging advancements in the field of microscopy.
Researchers who developed a machine learning algorithm to predict the adverse effects of new drug compounds have released it as an open source tool.
The Brain Metastasis Cell Lines Panel compiles research from various international institutions on the numerous brain metastasis cell lines that have been developed, in hopes collaboration will expedite research and drug development.
The autonomous robot scientist can independently perform experimental procedures and makes its own decisions about which tests to perform.
The genomic research platform will initially be used to help fast-track COVID-19 drug research and development, before being leveraged against other diseases, such as cancer.
Phoebe Chubb explores how digitalisation is shaking up the world of drug discovery and development by increasing productivity and reducing human error.
Software to help synthetic and medicinal chemists process and analyse all their spectral data in a single location.
Eliminate manual transcription, automate analytical data processing, and make decisions based on data directly linked with high throughput experiments.
Read how Takeda simplified analytical data processing for their Process and Medicinal chemists by consolidating to a single piece of software.
Learn how method development software helped Janssen Pharmaceuticals reduce method development time by 80% with a 25-fold increase in method quality
Track the emergence and fate of impurities throughout drug development, attach all the relevant analytical data, and store searchable knowledge.
Rick Wagner of ZebiAI and Patrick Riley of Google Accelerated Science (GAS) discuss the development and benefits of a new machine learning drug discovery platform.
26 June 2020 | By Tecan
This webinar described the recent efforts to identify small molecule therapeutics for the treatment of SARS-CoV-2 infection and COVID-19 disease.
Researchers have developed a video and model-building programme for other scientists to build full-length COVID-19 S protein models.
An artificial intelligence platform available online has been designed to help researchers track the genetics of SARS-CoV-2 as it moves from person to person.